Magstim is the pioneer in Transcranial Magnetic Stimulation (TMS). The significant majority of studies published worldwide in the field of magnetic stimulation have been carried out by researchers using Magstim equipment.
Magstim design, develop and market medical devices used in neuroscience research labs, clinical institutions and psychiatric centres. Magstim provide clinicians and researchers with state-of-the-art stimulation and monitoring equipment to facilitate the assessment, protection and improvement in function of the human nervous system.
Receiving FDA clearance in 2015 for the treatment of drug resistant Major Depressive Disorder (MDD) in the United States, the Magstim Rapid2 Therapy System is also currently being used by NHS trusts in the UK, Europe and in many countries in the world.